If I felt the same as you I would buy lots more SRX (shares keep getting cheaper) and not worry about Clinuvel (shares keep getting more expensive).
Alternatively you could read the 4C which shows that Clinuvel is already profitable and will become much more so with further take up in Europe, not to mention US.
Monthly sales breakdown would be virtually useless at this stage of development. In market for 4 months only.
Clinuvel will have a market cap of 1 billion before SRX reach 2 billion IMO.
Still Undervalued, page-20
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.12 |
Change
0.250(1.80%) |
Mkt cap ! $706.8M | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.17 | $13.90 | $675.2K | 48.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 293 | $14.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.12 | 261 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |